Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...

TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...

Here’s how to get relief from the nausea, anxiety, pain, and other symptoms of advanced prostate cancer and its treatments. Palliative care can make life more manageable during cancer treatment, but ...